HSBC Holdings’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,969
Closed -$486K 3138
2025
Q4
$486K Buy
+33,969
New +$588K ﹤0.01% 2332
2025
Q3
Sell
-18,194
Closed -$392K 3026
2025
Q2
$392K Sell
18,194
-5,919
-25% -$88K ﹤0.01% 2290
2025
Q1
$313K Buy
24,113
+632
+3% +$9.38K ﹤0.01% 2347
2024
Q4
$314K Buy
23,481
+275
+1% +$4.43K ﹤0.01% 2471
2024
Q3
$495K Buy
23,206
+5,001
+27% +$90.1K ﹤0.01% 2013
2024
Q2
$293K Buy
18,205
+286
+2% +$5.26K ﹤0.01% 2305
2024
Q1
$266K Sell
17,919
-7,284
-29% -$99.8K ﹤0.01% 2517
2023
Q4
$231K Buy
25,203
+6,813
+37% +$47K ﹤0.01% 2403
2023
Q3
$101K Buy
+18,390
New +$129K ﹤0.01% 2547
2023
Q1
Sell
-57,901
Closed -$141K 2946
2022
Q4
$141K Buy
+57,901
New +$181K ﹤0.01% 2849

Other funds holding OSCR

HSBC Holdings's OSCR Position: Q1 2026 in Review

HSBC Holdings sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 33,969 shares — an estimated $486K sold.

HSBC Holdings first reported a position in OSCR in Q4 2022 and held it in 10 quarters. The position peaked at $495K in Q3 2024. 331 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • HSBC Holdings reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 33,969 Oscar Health shares in Q1 2026, an estimated $486K.
  • HSBC Holdings first reported a position in Oscar Health in Q4 2022 and held it in 10 quarters.
  • HSBC Holdings's Oscar Health position peaked at $495K in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.